Phase 3 Randomized Clinical Trial Evaluating the Safety of Reproxalap in Patients With Dry Eye Disease.

Radcliffe NM, Sheppard J, Simmons B, Owen D, Nguyen A, Cavanagh B, Brady TC

Open source

DOI
10.1007/s40123-026-01379-0
Published
2026 May
Container
Ophthalmology and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40123-026-01379-0,
  title = {Phase 3 Randomized Clinical Trial Evaluating the Safety of Reproxalap in Patients With Dry Eye Disease.},
  author = {Radcliffe NM and Sheppard J and Simmons B and Owen D and Nguyen A and Cavanagh B and Brady TC},
  year = {2026},
  journal = {Ophthalmology and therapy},
  doi = {10.1007/s40123-026-01379-0},
  url = {https://doi.org/10.1007/s40123-026-01379-0}
}

RIS

TY  - JOUR
TI  - Phase 3 Randomized Clinical Trial Evaluating the Safety of Reproxalap in Patients With Dry Eye Disease.
AU  - Radcliffe NM
AU  - Sheppard J
AU  - Simmons B
AU  - Owen D
AU  - Nguyen A
AU  - Cavanagh B
AU  - Brady TC
PY  - 2026
JO  - Ophthalmology and therapy
DO  - 10.1007/s40123-026-01379-0
UR  - https://doi.org/10.1007/s40123-026-01379-0
ER  - 

APA

NM, R., J, S., B, S., D, O., A, N., B, C., & TC, B. (2026). Phase 3 Randomized Clinical Trial Evaluating the Safety of Reproxalap in Patients With Dry Eye Disease.. Ophthalmology and therapy. https://doi.org/10.1007/s40123-026-01379-0

Source records